Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

May 1, 2024 Pharmacy Practice Forum


The Premier Pharmacy Practice Forum webinar will feature one 60-minute Pharmacy Practice presentation. We are pleased to provide knowledge-based ACPE-accredited Continuing Education (CE) credits to pharmacists and pharmacy technicians for the Pharmacy Practice Presentations during our bi-monthly webinar meetings.

 
 Noon – 1:00 PM EDT: Pharmacy Considerations for the Optimal Utilization of T-cell Engaging Bispecific Antibodies for Hematologic Malignancies
 
Speaker: Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, Clinical Oncology Pharmacy Manager, Pharmacy Services - Levine Cancer Institute, Atrium Health, Charlotte, NC

ACPE Universal Program ID# 0122-0000-24-007-L01-P/T 1.0 Contact Hour [0.1 CEU]

Date: May 1, 2024 12:00 PM - 01:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on May 01, 2024 12:10 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

Support/Credits

Premier, Inc. has received no outside support for the administration of this program.

 

 

 

   

Objectives

  • Review the pharmacology and indications of recently approved T-cell engaging bispecific antibodies for the treatment of hematologic malignancies
  • Evaluate efficacy data supporting the approval of bispecific antibodies for multiple myeloma and lymphomas
  • Describe supportive care strategies to prevent and manage adverse events associated with bispecific antibodies
  • Define best practices for pharmacies to overcome administration and operational challenges associated with bispecific antibodies

Speaker(s)/Author(s)

Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP
Clinical Oncology Pharmacy Manager, Atrium Health

Activity Number

0122-0000-24-007-L01-P/T
Date: 05/01/24
Time: 12:00 PM - 01:00 PM

CE Hours

1.00